[1]
H. Shalhoub and M. Reaney, “PROMIS® tools as endpoints in clinical trials: what should you know? A review of PROMIS® capabilities and the current regulatory space”, Int J Clin Trials, vol. 3, no. 4, pp. 174–179, Oct. 2016.